Literature DB >> 15331057

A molecular modeling and QSAR study of suppressors of the growth of Trypanosoma cruzi epimastigotes.

Carlos Henrique Tomich de Paula da Silva1, Sergio Marcos Sanches, Carlton Anthony Taft.   

Abstract

In this work, we have used molecular modeling and QSAR tools to study 18 dithiocarbamate suppressors of the growth of Trypanosoma cruzi epimastigotes, which have been reported in the literature as superoxide dismutase (SOD) inhibitors. The principal component analysis (PCA) showed that the descriptors superficial area, heat of formation, logarithm of the partition coefficient, charge of the nitrogen atom from the dithiocarbamate group and Charges of the two carbon atoms adjacent to that nitrogen are responsible for the classification between the higher and lower trypanomicid activity. Using multiple linear regression (MLR) and docking methods it was possible to identify the probable bioactive isomers that suppress of the growth of T. cruzi epimastigotes. Our best partial least square (PLS) model obtained with these six descriptors yields a good correlation between experimental and predicted biological activities and compares two different SODs as possible target for interaction with the dithiocarbamates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331057     DOI: 10.1016/j.jmgm.2004.03.013

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  2 in total

1.  Probing the opportunities for designing anthelmintic leads by sub-structural topology-based QSAR modelling.

Authors:  Prabodh Ranjan; Mohd Athar; Prakash Chandra Jha; Kari Vijaya Krishna
Journal:  Mol Divers       Date:  2018-04-02       Impact factor: 2.943

2.  Homology modeling and molecular interaction field studies of alpha-glucosidases as a guide to structure-based design of novel proposed anti-HIV inhibitors.

Authors:  C H Tomich; P da Silva; Ivone Carvalho; C A Taft
Journal:  J Comput Aided Mol Des       Date:  2005-02       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.